Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05131217 · ClinicalTrials.gov registry record · NA
Effects of Acute Exercise Intensity on Cerebral Blood Flow and Cognitive Function in Older Adults
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05131217: Completed NA study, sponsored by University of Virginia.
NCT05131217 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05131217, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study will analyze the influence of acute bout exercise intensities (continuous moderate and HIIT) on middle cerebral artery velocity (MCAv) to identify which intensity elicits the greatest increase in CBF in older adults (65+ yrs). Additionally, this study will help verify positive correlations between MCAv and cognitive function. These findings are important in determining the optimal exercise prescription for increased resilience against the age-related cognitive degradation.
Primary Outcome
Blood flow velocity measured in the Middle Cerebral Artery via Transcranial Doppler probe secured to the right temporal window.
Interventions
- OTHER Control
- OTHER Acute bout of Continuous Moderate Intensity Exercise
- OTHER Acute bout of High Intensity Interval Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2022-01-14 |
| Est. Completion | 2023-05-01 |
| Phase | NA |
What the finished NCT05131217 record still lists
NCT05131217 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT05131217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05131217 about?
NCT05131217 is a clinical study titled "Effects of Acute Exercise Intensity on Cerebral Blood Flow and Cognitive Function in Older Adults". This study will analyze the influence of acute bout exercise intensities (continuous moderate and HIIT) on middle cerebral artery velocity (MCAv) to identify which intensity elicits the greatest increase in CBF in older adults (65+ yrs). Additionally, this study will help verify positive correlation...
What is the current status of trial NCT05131217?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-01-14. Estimated completion is 2023-05-01.
What interventions are being tested in trial NCT05131217?
The interventions under investigation include: Control (OTHER), Acute bout of Continuous Moderate Intensity Exercise (OTHER), Acute bout of High Intensity Interval Training (OTHER).
Who is sponsoring clinical trial NCT05131217?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05131217's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI